Home > Healthcare > Medical Devices > Diagnostic Devices > Helicobacter Pylori Testing Market

Helicobacter Pylori Testing Market Analysis

  • Report ID: GMI4408
  • Published Date: Nov 2022
  • Report Format: PDF

Helicobacter Pylori Testing Market Analysis

On the basis of the test, the helicobacter pylori testing market is bifurcated into invasive and non-invasive helicobacter pylori tests. Amongst them, invasive helicobacter test segment is poised to register a 6.5% CAGR from 2023 to 2032, driven by the efficacy and cost-effectiveness of rapid urease tests. The demand for invasive testing method is also high among patients do not correspond well to antibiotic therapy, have symptoms of severe gastric problems, and further require gastric endoscopy.

 

On the basis of the method, the helicobacter pylori testing market is categorized into laboratory-based tests and point-of-care (POC) tests. The POC tests segment accounted for a business share of more than 35% in 2022, due to its non-invasive nature and its ability to deliver fast results. This is also attributed to collaborative research initiatives by leading industry giants and increasing R&D spending, which is further encouraging technological advancements as well as new product launches.
 

Global Helicobacter Pylori Testing Market, By End-use

Based on end-use, the helicobacter pylori testing market is segmented into clinics, hospitals, diagnostic labs, and others. The clinic segment is projected to depict over 6% CAGR from 2023 to 2032, owing to the rising patient preference for clinics due to affordability and quality care. This is driven by the high-quality treatment and quick assistance offered by clinics, which provides the desired treatment results at a reasonable cost. In addition, the high-end services offered by clinics through effective disease management strategies are further set to spur segment expansion.
 

Global Helicobacter Pylori Testing Market, By Region

Asia Pacific helicobacter pylori testing market was valued at more than USD 100 million in 2022 and is further expected to witness over 8.5% CAGR from 2023 to 2032. Revenue growth is slated to be fueled by the rising occurrences of infectious ailments and increasing aging population in the region. Poor healthcare infrastructure and low awareness about good sanitary practices across developing APAC economies is further projected to fuel the demand for helicobacter pylori tests.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for helicobacter pylori testing held a valuation of over USD 447 million and is slated to grow at over 6.5% CAGR between 2023 and 2032.

Invasive test segment is anticipated to grow at 6.5% CAGR from 2023 to 2032, driven by the efficacy and affordability of rapid urease tests, and increasing demand from patients who do not correspond well to antibiotic therapy.

APAC helicobacter pylori testing market is poised to grow at over 8.5% CAGR from 2023 to 2032, driven by increasing instances of infectious diseases, a rapidly growing aging population, poor sanitation practices, and healthcare infrastructure in the region.

Some of the leading market contenders include Biohit Oyj, Avanos Corporate, Bio-Rad Laboratories, bioMerieux SA, Gulf Coast Scientific, Cardinal Health, Inc., Medline Industries, among others.

Helicobacter Pylori Testing Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 337
  • Countries covered: 22
  • Pages: 204
 Download Free Sample